Cargando…

Reappraisal of trifluperidol against Nsp3 as a potential therapeutic for novel COVID-19: a molecular docking and dynamics study

Novel COVID-19 is a highly infectious disease that is caused by the recently discovered SARS-CoV-2. It is a fast-spreading disease that urgently requires therapeutics. The current study employed computational regression methods to target the ADP-ribose phosphatase (ADRP) domain of Nsp3 using FDA-app...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandey, Ajita, Sharma, Mohit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285112/ https://www.ncbi.nlm.nih.gov/pubmed/34290823 http://dx.doi.org/10.2217/fvl-2020-0361

Ejemplares similares

Exploring the therapeutic nature of limonoids and triterpenoids against SARS-CoV-2 by targeting nsp13, nsp14, and nsp15 through molecular docking and dynamics simulations
por: Vardhan, Seshu, et al.
Publicado: (2021)

Multi-targeting approach for nsp3, nsp9, nsp12 and nsp15 proteins of SARS-CoV-2 by Diosmin as illustrated by molecular docking and molecular dynamics simulation methodologies
por: Kumar, Sumit, et al.
Publicado: (2021)

Addressing the potential role of curcumin in the prevention of COVID-19 by targeting the Nsp9 replicase protein through molecular docking
por: Kumar, Mohit, et al.
Publicado: (2021)

Potential phytochemical inhibitors of SARS-CoV-2 helicase Nsp13: a molecular docking and dynamic simulation study
por: Vivek-Ananth, R. P., et al.
Publicado: (2021)

Molecular Modeling and Docking Study to Elucidate Novel Chikungunya Virus nsP2 Protease Inhibitors
por: Agarwal, T., et al.
Publicado: (2015)

Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials
por: Danysz, Wojciech, et al.
Publicado: (2021)

Screening of FDA-approved compound library identifies potential small-molecule inhibitors of SARS-CoV-2 non-structural proteins NSP1, NSP4, NSP6 and NSP13: molecular modeling and molecular dynamics studies
por: Sundar, Shobana, et al.
Publicado: (2021)

Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations
por: Zrieq, Rafat, et al.
Publicado: (2021)

Molecular Docking of Cyanine and Squarylium Dyes with NSP15 Endoribonuclease of the SARS-CoV-2 Coronavirus
por: Pronkin, P. G., et al.
Publicado: (2022)

Exploring the potential of novel phenolic compounds as potential therapeutic candidates against SARS-CoV-2, using quantum chemistry, molecular docking and dynamic studies
por: Zia, Maimoona, et al.
Publicado: (2021)

Carotenoids as Novel Therapeutic Molecules Against Neurodegenerative Disorders: Chemistry and Molecular Docking Analysis
por: Lakey-Beitia, Johant, et al.
Publicado: (2019)

The NSP14/NSP10 RNA repair complex as a Pan-coronavirus therapeutic target
por: Rona, Gergely, et al.
Publicado: (2021)

Molecular docking investigation of calotropone as a potential natural therapeutic agent against pancreatic cancer
por: Purnama, Agnia, et al.
Publicado: (2022)

Molecular dynamic simulations reveal anti-SARS-CoV-2 activity of mitocurcumin by potentially blocking innate immune evasion proteins NSP3 and NSP16
por: Pal, Debojyoti, et al.
Publicado: (2022)

Reappraisal of the Therapeutic Role of Celecoxib in Cholangiocarcinoma
por: Yeh, Chun-Nan, et al.
Publicado: (2013)

In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation
por: Kumar, Durgesh, et al.
Publicado: (2020)

Virtual screening of molecular databases for potential inhibitors of the NSP16/NSP10 methyltransferase from SARS-CoV-2
por: Gomes, João Pedro Agra, et al.
Publicado: (2022)

Therapeutic potential of N-acetyl cysteine during COVID-19 epoch
por: Kapur, Ajita, et al.
Publicado: (2022)

Computational investigation of potent inhibitors against SARS-CoV-2 2′-O-methyltransferase (nsp16): Structure-based pharmacophore modeling, molecular docking, molecular dynamics simulations and binding free energy calculations
por: Shi, Liying, et al.
Publicado: (2022)

Molecular docking and pharmacokinetic studies of phytocompounds from Nigerian Medicinal Plants as promising inhibitory agents against SARS-CoV-2 methyltransferase (nsp16)
por: Saliu, Tolulope Peter, et al.
Publicado: (2021)

Reappraisal of Antihypertensive Medicine Doxazosin and Carvedilol as a Potential Therapeutic for Hepatic Fibrosis
por: Paik, Yong-Han
Publicado: (2016)

Soyasapogenol-B as a Potential Multitarget Therapeutic Agent for Neurodegenerative Disorders: Molecular Docking and Dynamics Study
por: Iqbal, Danish, et al.
Publicado: (2022)

In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2
por: Deshpande, Rujuta R., et al.
Publicado: (2020)

Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation
por: Cava, Claudia, et al.
Publicado: (2021)

Network pharmacology- and molecular docking-based investigation of the therapeutic potential and mechanism of daucosterol against multiple myeloma
por: Zeng, Junquan, et al.
Publicado: (2023)

Coronavirus NSP6 protein (nsp6)
Publicado: (2014)

Exploring the Therapeutic Ability of Fenugreek against Type 2 Diabetes and Breast Cancer Employing Molecular Docking and Molecular Dynamics Simulations
por: Rampogu, Shailima, et al.
Publicado: (2018)

Structural insights into type I and type II of nsp4 porcine reproductive and respiratory syndrome virus (nsp4 PRRSV) by molecular dynamics simulations
por: Aeksiri, Niran, et al.
Publicado: (2017)

Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment
por: Jung, Lindsey S, et al.
Publicado: (2020)

In Silico Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10
por: Eissa, Ibrahim H., et al.
Publicado: (2021)

Insighting isatin derivatives as potential antiviral agents against NSP3 of COVID-19
por: Ilyas, Mubashar, et al.
Publicado: (2022)

Identification of novel mutations in the methyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2
por: Azad, Gajendra Kumar
Publicado: (2020)

Insights from molecular docking and molecular dynamics on the potential of vitexin as an antagonist candidate against lipopolysaccharide (LPS) for microglial activation in neuroinflammation
por: Yahaya, M. A. F., et al.
Publicado: (2021)

Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2
por: Machitani, Mitsuhiro, et al.
Publicado: (2022)

Molecular docking studies, molecular dynamics and ADME/tox reveal therapeutic potentials of STOCK1N-69160 against papain-like protease of SARS-CoV-2
por: Elekofehinti, Olusola Olalekan, et al.
Publicado: (2020)

In silico Prediction, Characterization, Molecular Docking, and Dynamic Studies on Fungal SDRs as Novel Targets for Searching Potential Fungicides Against Fusarium Wilt in Tomato
por: Aamir, Mohd, et al.
Publicado: (2018)

Docking and Molecular Dynamic of Microalgae Compounds as Potential Inhibitors of Beta-Lactamase
por: Pestana-Nobles, Roberto, et al.
Publicado: (2022)

QSAR Studies, Molecular Docking, Molecular Dynamics, Synthesis, and Biological Evaluation of Novel Quinolinone-Based Thiosemicarbazones against Mycobacterium tuberculosis
por: Valencia, Jhesua, et al.
Publicado: (2022)

Resolving the Dynamic Motions of SARS-CoV-2 nsp7 and nsp8 Proteins Using Structural Proteomics
por: Courouble, Valentine V., et al.
Publicado: (2021)

Molecular dynamics simulations of the flexibility and inhibition of SARS-CoV-2 NSP 13 helicase
por: Raubenolt, Bryan A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9vkn8jpmicnuqrdiamdfebjapj